Blog

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

For Immediate Release

Chicago, IL – June 12, 2025– Today, Zacks Investment Ideas feature NuScale Power Corp. SMR and Oklo Inc. OKLO.

Buy Soaring Nuclear Energy Stocks Now, or Wait for the Dip?

For Immediate Release

Chicago, IL – June 12, 2025– Today, Zacks Investment Ideas feature highlights Carvana's CVNA, Beyond Meat BYND, Sprouts Farmers Market SFM, Urban Outfitters URBN and

Newmont Corporation (NEM) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, NEM broke through the 20-day moving average, which

For Immediate Release

Chicago, IL – June 12, 2025– Today, Zacks Investment Ideas feature highlights Netflix NFLX, The Walt Disney Co. DIS, Amazon AMZN and Warner Bros. Discovery WBD.

Warner Bros.

For Immediate Release

Chicago, IL – June 12, 2025– Zacks Director of Research Sheraz Mian says, "The quarter started with significant pressure on Tech sector estimates, but the negative revisions

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

For the quarter ended April 2025, Lovesac (LOVE) reported revenue of $138.37 million, up 4.3% over the same period last year. EPS came in at -$0.73, compared to -$0.83 in the year-ago quarter.

The

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

The AI trade has become something of a consensus on Wall Street. From mega cap tech to speculative startups, nearly every corner of the market is angling for exposure to the next wave of artificial

For Immediate Release

Chicago, IL – June 12, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

For Immediate Release

Chicago, IL – June 12, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

For Immediate Release

Chicago, IL – June 12, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Nutrien Ltd.’s NTR shares have popped 23.7% over the past three months. The company has also outperformed the Zacks Fertilizers industry’s 17.5% rise over the same time frame. NTR has also topped

For Immediate Release

Chicago, IL – June 12, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Have you been paying attention to shares of Brainsway Ltd. Sponsored ADR (BWAY)? Shares have been on the move with the stock up 14.2% over the past month. The stock hit a new 52-week high of $12 in

Did you analyze how Broadcom Inc. (AVGO) fared in its international operations for the quarter ending April 2025? Given the widespread global presence of this chipmaker, scrutinizing the trends in

Bristol Myers BMY announced that the late-stage study on Sotyktu (deucravacitinib) in adults with active psoriatic arthritis (PsA) met its primary endpoint.

Sotyktu is an oral, selective tyrosine